Respiratory Muscle Weakness in Patients with Heart Failure: Time to Make It a Standard Clinical Marker and a Need for Novel Therapeutic Interventions?

J Card Fail. 2018 Apr;24(4):217-218. doi: 10.1016/j.cardfail.2018.02.007. Epub 2018 Mar 1.

Authors

Bryan J Taylor¹, T Scott Bowen²

Affiliations

¹ Faculty of Biological Sciences, School of Biomedical Sciences, University of Leeds, Leeds, UK. Electronic address: b.j.taylor@leeds.ac.uk.
² Faculty of Biological Sciences, School of Biomedical Sciences, University of Leeds, Leeds, UK.

PMID: 29499323
DOI: 10.1016/j.cardfail.2018.02.007

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biomarkers
Heart Failure*
Humans
Muscle Weakness*
Muscular Diseases
Respiratory Muscles

Substances

Biomarkers